Atherothrombosis and Coronary Artery Disease
Integrated basic and clinical research to study the etiology, pathogenesis, prevention, diagnosis, and treatment of CAD and atherothrombosis; translation of promising scientific and technological advances from discovery through preclinical studies to networks and multisite clinical trials.
Program Officers
Yves Rosenberg, M.D., M.P.H
Coronary artery disease; Methodology of cardiovascular clinical trials
301-435-0550
Jue Chen, M.B., M.S., Ph.D.
Acting Deputy Branch Chief, Program Officer
301-435-0532
Jerome Fleg, M.D.
Clinical cardiovascular disease; Exercise physiology
301-435-0420